Detalhe da pesquisa
1.
Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: The X-COVID-19 Randomized Trial.
Eur J Clin Invest
; 52(5): e13735, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34958123
2.
The challenge of infectious diseases consultations in the emergency department: an Italian nationwide survey.
New Microbiol
; 45(4): 260-268, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190370
3.
Long-acting drugs: people's expectations and physicians' preparedness. Are we readying to manage it? An Italian survey.
Medicine (Baltimore)
; 101(42): e30052, 2022 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36281167
4.
Increased Creatine Kinase May Predict A Worse COVID-19 Outcome.
J Clin Med
; 10(8)2021 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33923719
5.
The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission.
Sci Rep
; 11(1): 15619, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34341411
6.
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy.
Antivir Ther
; 14(3): 359-69, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19474470
7.
18-fluorodeoxyglucose positron emission tomography (FDG-PET) in patients with non-tuberculous mycobacterial infections.
J Infect
; 87(5): 462-464, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36935023
8.
Pharmacokinetic and safety of raltegravir in pregnancy.
Eur J Clin Pharmacol
; 68(8): 1231-2, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22382989
9.
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-week results of a randomized trial.
PLoS One
; 12(11): e0187393, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29161288
10.
Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women.
Infez Med
; 24(3): 217-21, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27668902
11.
Cost of HAART in Italy: multicentric evaluation and determinants from a large HIV outpatient cohort.
Clinicoecon Outcomes Res
; 7: 27-35, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25565872
12.
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.
J Infect
; 81(4): 647-679, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32592703
13.
The Effect of Switching to Maraviroc + Darunavir/Ritonavir Dual Therapy in Virologically Suppressed Patients on the Progression of Liver Fibrosis: Findings From a Randomized Study.
J Acquir Immune Defic Syndr
; 81(1): e17-e21, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789452
14.
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
Int J Antimicrob Agents
; 43(2): 189-94, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315315
15.
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.
PLoS One
; 7(7): e39222, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22808029
16.
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis).
J Acquir Immune Defic Syndr
; 46(3): 373-5, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18090302